Leverage Modern Technology and Software Solutions
The d-Control system provides a real-time database, capable of displaying online data, trends, alarms, and event logs, with the flexibility to integrate these datainto control strategies.
Ehanced Flexibility and Scalability
Each system supports up to 32 bioreactors and enables advanced control strategies by integrating third-party data. Customizable features address complex control require ments. System data can seamlessly feed into upper-level systems (MES, LIMS, ERP, etc.)
Optimized User Experience with Advanced Automa tion Tools
Operators can easily access key process data, including real-time process values, status information, operational parameters, and alarms with priority and timestamps. The interface is intuitive and user-friendly.
Accelerated Time-to-Market and Reduced Develop ment Costs
Facilitate seamless migration of laboratory research data and control strategies to pilot and production systems.
Th system architecture integrates hardware, software, and interfaces, creating a software solution specifically tailored for bioreactors.
Engineers and operators can efficiently monitor reactor operations and utilize tools to design and implement solutions. Connectivity with other systems is achieved through industry-standard OPC protocols, enabling system enhancement and optimization.
Uses open communication protocols with a scalable system architecture.
Customizable DeltaV Software
Provides tailored control strategies based on specific client requirements.
Alarm
Prioritizes alarms by importance, including factors such as operator relevance, acknowledgement status, activa tion state and designated responsibility area.
SMS Alarm
Sends real-time alarm notifications via SMS to designat ed personnel, ensuring timely resolution.
Offers MS-Excel-based reporting and analysis tools for easy integration of historical data into Excel spread sheets.
• Microbial and Cell Culture
• Fed-batch, Perfusion and Continuous Cell Culture
• Single-use Bioreactor Processes
• Stainless Steel Bioreactor Processes for Pilot-Scale and GMP Commercial Production